Thomas Proft

6.3k total citations · 1 hit paper
99 papers, 4.7k citations indexed

About

Thomas Proft is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Thomas Proft has authored 99 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Public Health, Environmental and Occupational Health, 49 papers in Infectious Diseases and 27 papers in Molecular Biology. Recurrent topics in Thomas Proft's work include Streptococcal Infections and Treatments (71 papers), Antimicrobial Resistance in Staphylococcus (43 papers) and Neonatal and Maternal Infections (37 papers). Thomas Proft is often cited by papers focused on Streptococcal Infections and Treatments (71 papers), Antimicrobial Resistance in Staphylococcus (43 papers) and Neonatal and Maternal Infections (37 papers). Thomas Proft collaborates with scholars based in New Zealand, Australia and Germany. Thomas Proft's co-authors include John D. Fraser, Edward N. Baker, Jacelyn M. S. Loh, Catherine Jia‐Yun Tsai, Fiona Clow, Hae Joo Kang, Richard Herrmann, Fasséli Coulibaly, Vickery L. Arcus and Ries J. Langley and has published in prestigious journals such as Science, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Thomas Proft

95 papers receiving 4.6k citations

Hit Papers

Galleria mellonellainfect... 2016 2026 2019 2022 2016 100 200 300 400 500

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Thomas Proft 1.7k 1.6k 1.6k 1.1k 638 99 4.7k
Eva Medina 2.1k 1.3× 1.1k 0.6× 2.0k 1.3× 2.7k 2.4× 571 0.9× 128 6.6k
Suzan H. M. Rooijakkers 2.4k 1.4× 687 0.4× 2.1k 1.3× 2.0k 1.8× 941 1.5× 109 5.3k
Vijay Pancholi 1.0k 0.6× 1.2k 0.8× 1.5k 0.9× 445 0.4× 460 0.7× 49 3.6k
Jovanka M. Voyich 3.1k 1.9× 1.3k 0.8× 3.1k 1.9× 1.5k 1.3× 917 1.4× 79 6.1k
Peter Valentin‐Weigand 1.8k 1.1× 2.7k 1.7× 855 0.5× 793 0.7× 1.0k 1.6× 133 4.7k
Scott D. Kobayashi 2.0k 1.2× 706 0.4× 2.2k 1.4× 1.8k 1.6× 509 0.8× 76 5.4k
Michael Kehoe 1.6k 1.0× 1.6k 1.0× 1.3k 0.8× 601 0.5× 320 0.5× 77 3.6k
Jan‐Ingmar Flock 2.1k 1.3× 1.1k 0.6× 2.1k 1.3× 439 0.4× 584 0.9× 104 4.0k
John D. Fraser 2.2k 1.3× 1.4k 0.9× 1.2k 0.8× 2.3k 2.0× 362 0.6× 121 5.2k
Kelly S. Doran 876 0.5× 2.4k 1.4× 1.4k 0.9× 645 0.6× 1.2k 1.9× 97 5.2k

Countries citing papers authored by Thomas Proft

Since Specialization
Citations

This map shows the geographic impact of Thomas Proft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Proft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Proft more than expected).

Fields of papers citing papers by Thomas Proft

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Proft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Proft. The network helps show where Thomas Proft may publish in the future.

Co-authorship network of co-authors of Thomas Proft

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Proft. A scholar is included among the top collaborators of Thomas Proft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Proft. Thomas Proft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vesty, Anna, Prachi Sharma, Natalie Lorenz, et al.. (2024). The Emergence and Impact of the M1UK Lineage on Invasive Group A Streptococcus Disease in Aotearoa New Zealand. Open Forum Infectious Diseases. 11(8). ofae457–ofae457. 6 indexed citations
2.
Tsai, Catherine Jia‐Yun, et al.. (2024). Group A Streptococcus Pili—Roles in Pathogenesis and Potential for Vaccine Development. Microorganisms. 12(3). 555–555.
3.
Tsai, Catherine Jia‐Yun, et al.. (2023). The Cell Wall Deacetylases Spy1094 and Spy1370 Contribute to Streptococcus pyogenes Virulence. Microorganisms. 11(2). 305–305. 1 indexed citations
4.
Tsai, Catherine Jia‐Yun, et al.. (2023). Expanding strain coverage of a group A Streptococcus pilus–expressing Lactococcus lactis mucosal vaccine. Immunology and Cell Biology. 101(6). 545–555. 5 indexed citations
5.
Young, Paul G., Natalie Lorenz, Jacelyn M. S. Loh, et al.. (2023). Identification of an immunodominant region on a group A Streptococcus T-antigen reveals temperature-dependent motion in pili. Virulence. 14(1). 2180228–2180228. 1 indexed citations
6.
Loh, Jacelyn M. S., et al.. (2023). Different Group A Streptococcus pili lead to varying proinflammatory cytokine responses and virulence. Immunology and Cell Biology. 102(1). 21–33. 1 indexed citations
7.
Ting, Yi Tian, et al.. (2022). Complement evasion factor (CEF), a novel immune evasion factor of Streptococcus pyogenes. Virulence. 13(1). 225–240. 7 indexed citations
8.
Loh, Jacelyn M. S., et al.. (2022). Functional Characterisation of Two Novel Deacetylases from Streptococcus pyogenes. SHILAP Revista de lepidopterología. 13(2). 323–331. 1 indexed citations
9.
Loh, Jacelyn M. S., et al.. (2017). Streptococcus pyogenes nuclease A (SpnA) mediated virulence does not exclusively depend on nuclease activity. Journal of Microbiology Immunology and Infection. 53(1). 42–48. 10 indexed citations
10.
Whitcombe, Alana L., Paul G. Young, Polly E. Atatoa Carr, et al.. (2017). The novel Group A Streptococcus antigen SpnA combined with bead-based immunoassay technology improves streptococcal serology for the diagnosis of acute rheumatic fever. Journal of Infection. 76(4). 361–368. 9 indexed citations
11.
Loh, Jacelyn M. S., Catherine Jia‐Yun Tsai, & Thomas Proft. (2017). The ability of Group A streptococcus to adhere to immortalized human skin versus throat cell lines does not reflect their predicted tissue tropism. Clinical Microbiology and Infection. 23(9). 677.e1–677.e3. 7 indexed citations
12.
Proft, Thomas. (2013). Bacterial toxins : genetics, cellular biology and practical applications. 12 indexed citations
13.
Commons, Robert J., Pierre R. Smeesters, Thomas Proft, et al.. (2013). Streptococcal superantigens: categorization and clinical associations. Trends in Molecular Medicine. 20(1). 48–62. 88 indexed citations
14.
Proft, Thomas. (2009). Microbial toxins : current research and future trends. 16 indexed citations
15.
Kang, Hae Joo, Fasséli Coulibaly, Fiona Clow, Thomas Proft, & Edward N. Baker. (2007). Stabilizing Isopeptide Bonds Revealed in Gram-Positive Bacterial Pilus Structure. Science. 318(5856). 1625–1628. 278 indexed citations
17.
Proft, Thomas. (2005). Microbial toxins: molecular and cellular biology.. Mikrobiyoloji Bulteni. 53(1). 106–113. 21 indexed citations
18.
Unnikrishnan, Meera, Daniel M. Altmann, Thomas Proft, et al.. (2002). The Bacterial Superantigen Streptococcal Mitogenic Exotoxin Z Is the Major Immunoactive Agent of Streptococcus pyogenes. The Journal of Immunology. 169(5). 2561–2569. 65 indexed citations
19.
Proft, Thomas, et al.. (1999). Identification and Characterization of Novel Superantigens from Streptococcus pyogenes . The Journal of Experimental Medicine. 189(1). 89–102. 145 indexed citations
20.
Proft, Thomas & John D. Fraser. (1998). Superantigens: Just Like Peptides Only Different. The Journal of Experimental Medicine. 187(6). 819–821. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026